Table 2.

Univariate analyses of risks for recurrence and all-cause mortality in 88 women who received chemotherapy and radiation for endometrial cancer

Patient Characteristic	Risk of recurrence HR (95%CI)*	Risk of death HR (95%CI)
Ages 70+	1.45 (0.77–2.71)	1.19 (0.61–2.34)
BMI < 20	0.56 (0.13–2.31)	0.97 (1.00–1.14)
Age at diagnosis	1.07 (1.01–1.13)	1.07 (1.01–1.13)
ECOG-PS > 0	1.86 (0.85–4.09)	0.99 (0.38–2.57)
Charlson Comorbidity Score	1.42 (0.69–2.91)	2.01(0.88–4.62)
Hgb < 10.0	1.68 (0.77–3.67)	1.57 (0.65–3.79)
Albumin < 3.5	2.20 (1.14–4.24)	1.89 (0.92–3.90)
Weight loss > 5% in 6 months	1.95 (0.89–4.24)	2.27 (1.03–5.03)
Osteopenia or osteoporosis	1.49 (0.72–3.06)	2.07 (1.00–4.33)
Stage III at diagnosis	1.22 (0.64–2.33)	2.00 (0.91–4.42)
Grade III at diagnosis	0.84 (0.41–1.73)	1.48 (0.61–3.56)
1 Frailty indicator present	2.48 (1.09–5.62)	2.39 (1.03–5.53)
> 1 Frailty indicator present	3.11 (1.35–7.19)	2.54 1.05–6.14)

^*Hazard ratios (HR) and 95% Confidence Intervals (95%CI) calculated by Cox proportional hazards models.